Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Metronidazole vaginal gel 0.75% (MetroGel-Vaginal): a brief review.

× No keyword cloud information.

11 in total

1. Systemic absorption of metronidazole by the vaginal route.

Authors: M M Alper; B N Barwin; W M McLean; I J McGilveray; S Sved
Journal: Obstet Gynecol Date: 1985-06 Impact factor: 7.661

Review 2. Symposium on antimicrobial agents. Metronidazole.

Authors: J E Rosenblatt; R S Edson
Journal: Mayo Clin Proc Date: 1987-11 Impact factor: 7.616

3. Pharmacokinetics of intravaginal metronidazole gel.

Authors: F E Cunningham; D M Kraus; L Brubaker; J H Fischer
Journal: J Clin Pharmacol Date: 1994-11 Impact factor: 3.126

4. Efficacy of intravaginal 0.75% metronidazole gel for the treatment of bacterial vaginosis.

Authors: S L Hillier; C Lipinski; A M Briselden; D A Eschenbach
Journal: Obstet Gynecol Date: 1993-06 Impact factor: 7.661

Review 5. Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives.

Authors: A H Lau; N P Lam; S C Piscitelli; L Wilkes; L H Danziger
Journal: Clin Pharmacokinet Date: 1992-11 Impact factor: 6.447

Review 6. Metronidazole: utilization in the obstetric and gynecologic patient.

Authors: J R Schwebke
Journal: Sex Transm Dis Date: 1995 Nov-Dec Impact factor: 2.830

Review 7. Mechanisms of selective toxicity of metronidazole and other nitroimidazole drugs.

Authors: D I Edwards
Journal: Br J Vener Dis Date: 1980-10

8. Bacterial vaginosis: efficacy and safety of intravaginal metronidazole treatment.

Authors: C H Livengood; J A McGregor; D E Soper; E Newton; J L Thomason
Journal: Am J Obstet Gynecol Date: 1994-03 Impact factor: 8.661

9. Action of clinically utilized 5-nitroimidazoles on microorganisms.

Authors: M Müller
Journal: Scand J Infect Dis Suppl Date: 1981

10. Systemic concentrations of metronidazole and its main metabolites after intravenous oral and vaginal administration.

Authors: B Fredricsson; B Hagström; C E Nord; A Rane
Journal: Gynecol Obstet Invest Date: 1987 Impact factor: 2.031

2 in total

1. Chitosan-Based Nanomedicine to Fight Genital Candida Infections: Chitosomes.

Authors: Toril Andersen; Ekaterina Mishchenko; Gøril Eide Flaten; Johanna U Ericson Sollid; Sofia Mattsson; Ingunn Tho; Nataša Škalko-Basnet
Journal: Mar Drugs Date: 2017-03-04 Impact factor: 5.118

2. BASIC study: is intravaginal boric acid non-inferior to metronidazole in symptomatic bacterial vaginosis? Study protocol for a randomized controlled trial.

Authors: Melinda Zeron Mullins; Konia M Trouton
Journal: Trials Date: 2015-07-26 Impact factor: 2.279

2 in total